“…During the last decade, the role of inflammasomes in tumorigenesis, antitumor immunity, and response to cancer therapy has been investigated in many cancer models, with conflicting findings [ 25 , 39 , 40 , 41 ]. While inflammasome‐associated IL‐1β secretion by tumor‐associated macrophages and cancer‐associated fibroblasts may promote tumor growth and metastasis by suppressing antitumor immunity [ 42 , 43 , 44 ], inflammasome activation also enhances antitumor activity of CD8 + T cells and NK cells through IL‐18, promotes tumor infiltration of lymphocytes, and strengthens the response to checkpoint inhibitors [ 45 , 46 , 47 , 48 ].…”